PISCES safety study of CTX cells in the treatment of patients with stable ischaemic stroke
Clinical Trial Stage: Phase I
Trial Purpose: To test safety of CTX cells delivered by injection into the damaged brains of male patients > 60 left moderately to severely disabled 6 months to 5 years following an ischaemic stroke
Status : Study completed
Efficacy study of CTX cells in patients with stable paresis of the arm following an ischaemic stroke
Clinical Trial Stage: Phase II
Trial Purpose: To determine if treatment at a dose of 20m cells improves recovery in use of paretic arm in stroke patients to justify a larger pivotal study
Status : Data Reported
Non-interventional, observational study for patients with stable ischaemic stroke to document clinical course and establish pool of patients for on-going trials
Clinical Trial Stage: Observational
Trial Purpose: To build data set in untreated disabled stroke patients and facilitate on-going clinical trials
Next milestone: Study completed, long term follow up data H2 2017
Ascending dose safety study of CTX cells in patients with lower limb ischaemia
Clinical Trial Stage: Phase I
Trial Purpose: To investigate the safety and tolerability of intramuscular injections of CTX cells in patients with peripheral arterial disease
Next milestone: Long term safety data H1 2018
Open label prospective study of the safety and tolerability of the human retinal progenitor cell (hRPC) therapy candidate in the treatment of patients with retinitis pigmentosa
Clinical Trial Stage: Phase I/II
Trial Purpose: To evaluate the safety, tolerability and preliminary efficacy of sub-retinally transplanted hRPCs in patients with advanced retinitis pigmentosa, the Phase II element of study is planned to be expanded to 20 patients.
Next milestone: Initial safety data H2 2017
Further information regarding our clinical trials, including relevant contact details, may be found on clinicaltrials.gov, a registry of clinical trials providing patients, family members, and members of the public free and easy access to information on clinical studies for a wide range of diseases and conditions: please click here.
